Many of us rely on our local hospital, but how do we know if it's safe? Or better than the other one down the road? Every year we expect our healthcare system to treat more patients with more problems and to ever higher standards. We clearly need useable information on performance. The NHS benefits from huge but complex databases, and it's my job to help doctors, managers and patients make sense of them.
After secondment to the public inquiry into the crimes of GP Harold Shipman, I devised the statistical methodology behind the flagship information tool of our commercial partners, Dr Foster. With my analysis, this tool correctly identified Mid Staffordshire NHS Trust as having unacceptably high death rates and was a trigger for the national regulator to investigate. My research today continues to measure and monitor the quality of healthcare in hospital and in the community for patients with chronic disease, such as heart failure and COPD, or multimorbidity using databases such as HES and CPRD. My heart failure work was cited in the 2019 NHS Long-term Plan.
Among my teaching roles, I am the Academic Lead for my "Statistical Analysis with R for Public Health" specialisation that's now live on Coursera and is part of Imperial's online Global MPH. I am also on the Programme Board responsible for the degree's delivery. As a consultant since 2016, I train the UK public sector on statistical thinking and data analysis to improve staff effectiveness.
et al., 2022, Impact of COVID-19 on outpatient appointments in children and young people in England: an observational study, Bmj Open, Vol:12, ISSN:2044-6055
et al., 2022, Socioeconomic deprivation and ethnicity inequalities in disruption to NHS hospital admissions during the COVID-19 pandemic: a national observational study, Bmj Quality & Safety, Vol:31, ISSN:2044-5415, Pages:590-598
et al., 2022, Factors associated with, and variations in, COVID-19 hospital death rates in England’s first two waves: observational study, Bmj Open, Vol:12, ISSN:2044-6055, Pages:1-11
et al., 2022, Cardio-metabolic factors and risk of dementia in people with type 2 diabetes in England: a large retrospective cohort study, DUK, SPRINGER, Pages:S402-S403, ISSN:0012-186X
et al., 2022, IMPACT OF TIME TO DIAGNOSIS ON INFLAMMATORY BOWEL DISEASE OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS, BMJ PUBLISHING GROUP, Pages:A52-A53, ISSN:0017-5749